selective ep2 receptor antagonist Search Results


N/A
EP2 receptor antagonist-1(Cat No.:I045076)is a selective inhibitor targeting the prostaglandin E2 receptor subtype EP2, which plays a key role in inflammation, pain, tumor progression, and neurodegeneration. By blocking EP2 receptor signaling, this compound reduces cAMP-mediated
  Buy from Supplier


90
Pharmacia Upjohn LLC prostaglandins selective ep2 and/or ep4 receptor agonists
Prostaglandins Selective Ep2 And/Or Ep4 Receptor Agonists, supplied by Pharmacia Upjohn LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selective+ep2+receptor+antagonist/prostaglandins+selective+ep2+and+or+ep4+receptor+agonists/us06900336-40-14-29
Average 90 stars, based on 1 article reviews
prostaglandins selective ep2 and/or ep4 receptor agonists - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Santen SAS selective prostaglandin ep2 receptor agonist omidenepag isopropyl 0.002
A: Conjunctival hyperemia score of 2.33 on a frontal image at 30 min in a 36-year-old male induced by <t>omidenepag</t> isopropyl. B: Conjunctival vessel occupancy (percent coverage). Percent coverage was 19.1% (according to the analysis software) at the same time point.
Selective Prostaglandin Ep2 Receptor Agonist Omidenepag Isopropyl 0.002, supplied by Santen SAS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selective+ep2+receptor+antagonist/selective+prostaglandin+ep2+receptor+agonist+omidenepag+isopropyl+0+002/pmc07549872-8-4-12
Average 90 stars, based on 1 article reviews
selective prostaglandin ep2 receptor agonist omidenepag isopropyl 0.002 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Synphora Inc ep2 receptor selective, agonistic prostaglandin derivatives
A: Conjunctival hyperemia score of 2.33 on a frontal image at 30 min in a 36-year-old male induced by <t>omidenepag</t> isopropyl. B: Conjunctival vessel occupancy (percent coverage). Percent coverage was 19.1% (according to the analysis software) at the same time point.
Ep2 Receptor Selective, Agonistic Prostaglandin Derivatives, supplied by Synphora Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selective+ep2+receptor+antagonist/ep2+receptor+selective++agonistic+prostaglandin+derivatives/pm23289354-304-8-0
Average 90 stars, based on 1 article reviews
ep2 receptor selective, agonistic prostaglandin derivatives - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Laviana Corporation ep2 receptor antagonist pf-04418948
A: Conjunctival hyperemia score of 2.33 on a frontal image at 30 min in a 36-year-old male induced by <t>omidenepag</t> isopropyl. B: Conjunctival vessel occupancy (percent coverage). Percent coverage was 19.1% (according to the analysis software) at the same time point.
Ep2 Receptor Antagonist Pf 04418948, supplied by Laviana Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selective+ep2+receptor+antagonist/ep2+receptor+antagonist+pf+04418948/10__1096_slash_fj__201600604r-91-1-8
Average 90 stars, based on 1 article reviews
ep2 receptor antagonist pf-04418948 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier



N/A
EP2 receptor antagonist-2 (CID891729) is an antagonist of EP2 receptor. EP2 receptor antagonist-2 inhibits the EP2 receptor activation induced by PGE2. EP2 receptor antagonist-2 also suppresses lactate dehydrogenase (LDH) release induced by N-methyl-D-aspartate (NMDA).
  Buy from Supplier

N/A
EP2 receptor antagonist-1 (compound 1) is a potent, reversible, and agonist dependent allosteric prostaglandin EP2 receptor antagonist. EP2 receptor antagonist-1 shows anti-inflammatory effectsForm:SolidIC50& Target:EP2
  Buy from Supplier

N/A
EP2 receptor antagonist-2 (Cat No.:I041696) is a selective small-molecule inhibitor of the prostaglandin E₂ (PGE₂) EP2 receptor. It is used in pharmacological research to investigate EP2-mediated signaling involved in inflammation, pain perception, immune modulation, and
  Buy from Supplier

N/A
EP2 receptor antagonist-1 (compound 1) is a potent, reversible, and agonist dependent allosteric prostaglandin EP2 receptor antagonist. EP2 receptor antagonist-1 shows anti-inflammatory effects.
  Buy from Supplier

Image Search Results


A: Conjunctival hyperemia score of 2.33 on a frontal image at 30 min in a 36-year-old male induced by omidenepag isopropyl. B: Conjunctival vessel occupancy (percent coverage). Percent coverage was 19.1% (according to the analysis software) at the same time point.

Journal: Cureus

Article Title: Evaluation of Patterns and Correlations of the Degree of Conjunctival Hyperemia Induced by Omidenepag Isopropyl 0.002% and Ripasudil 0.4%

doi: 10.7759/cureus.10368

Figure Lengend Snippet: A: Conjunctival hyperemia score of 2.33 on a frontal image at 30 min in a 36-year-old male induced by omidenepag isopropyl. B: Conjunctival vessel occupancy (percent coverage). Percent coverage was 19.1% (according to the analysis software) at the same time point.

Article Snippet: In 2018, the selective prostaglandin EP2 receptor agonist omidenepag isopropyl 0.002% (EYBELIS®; Santen Pharmaceutical, Co., Ltd., Osaka, Japan) was introduced in Japan.

Techniques: Software

Differences in the distribution of hyperemia patterns in  omidenepag  isopropyl- and ripasudil-administered eyes A significant difference in distribution was found between the two groups according to the χ2 test (P <0.001).

Journal: Cureus

Article Title: Evaluation of Patterns and Correlations of the Degree of Conjunctival Hyperemia Induced by Omidenepag Isopropyl 0.002% and Ripasudil 0.4%

doi: 10.7759/cureus.10368

Figure Lengend Snippet: Differences in the distribution of hyperemia patterns in omidenepag isopropyl- and ripasudil-administered eyes A significant difference in distribution was found between the two groups according to the χ2 test (P <0.001).

Article Snippet: In 2018, the selective prostaglandin EP2 receptor agonist omidenepag isopropyl 0.002% (EYBELIS®; Santen Pharmaceutical, Co., Ltd., Osaka, Japan) was introduced in Japan.

Techniques: